GnRH Analogues in the Prevention of Ovarian Hyperstimulation Syndrome

Author(s):
Pilar AlamaPilar Alama1, Jose BellverJose Bellver2, Carmen VidalCarmen Vidal1, Juan GilesJuan Giles1,*
1Department of Reproduction, IVI-Valencia, Plaza de la Policia Local, Valencia, Spain
2Department of Paediatrics, Obstetrics and Gynaecology, Faculty of Medicine. University of Valencia, Valencia, Spain

International Journal of Endocrinology and Metabolism:Vol. 11, issue 2; 107-16
Published online:Mar 31, 2013
Article type:Review Article
Received:Jul 08, 2012
Accepted:Aug 17, 2012
How to Cite:Alama P, Bellver J, Vidal C, Giles J. GnRH Analogues in the Prevention of Ovarian Hyperstimulation Syndrome. Int J Endocrinol Metab. 2013;11(2):. doi: https://doi.org/10.5812/ijem.5034

Abstract

Abstract:

The GnRH analogue (agonist and antagonist GnRH) changed ovarian stimulation. On the one hand, it improved chances of pregnancy to obtain more oocytes and better embryos. This leads to an ovarian hyper-response, which can be complicated by the ovarian hyperstimulation syndrome (OHSS). On the other hand, the GnRH analogue can prevent the incidence of OHSS: GnRH antagonist protocols, GnRH agonist for triggering final oocyte maturation, either together or separately, coasting, and the GnRH analogue may prove useful for avoiding OHSS in high-risk patients. We review these topics in this article.

Full Text

Full text is available in PDF

Crossmark
Crossmark
Checking
Share on
Cited by
Metrics

Ordering Reprints

Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC 

Search Relations

Author(s):

Related Articles